These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26856748)

  • 1. Knowledge and Uptake of Genetic Counseling and Colonoscopic Screening Among Individuals at Increased Risk for Lynch Syndrome and their Endoscopists from the Family Health Promotion Project.
    Patel SG; Ahnen DJ; Kinney AY; Horick N; Finkelstein DM; Hill DA; Lindor NM; MaCrae F; Lowery JT
    Am J Gastroenterol; 2016 Feb; 111(2):285-93. PubMed ID: 26856748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in screening behaviors and attitudes toward screening from pre-test genetic counseling to post-disclosure in Lynch syndrome families.
    Burton-Chase AM; Hovick SR; Peterson SK; Marani SK; Vernon SW; Amos CI; Frazier ML; Lynch PM; Gritz ER
    Clin Genet; 2013 Mar; 83(3):215-20. PubMed ID: 23414081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening adherence and cancer risk perceptions in colorectal cancer survivors with Lynch-like syndrome.
    Katz LH; Burton-Chase AM; Advani S; Fellman B; Polivka KM; Yuan Y; Lynch PM; Peterson SK
    Clin Genet; 2016 Mar; 89(3):392-8. PubMed ID: 26272410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and management of Lynch syndrome in the Middle East and North African countries: outcome of a survey in 12 countries.
    Sina M; Ghorbanoghli Z; Abedrabbo A; Al-Mulla F; Sghaier RB; Buisine MP; Cortas G; Goshayeshi L; Hadjisavvas A; Hammoudeh W; Hamoudi W; Jabari C; Loizidou MA; Majidzadeh-A K; Marafie MJ; Muslumov G; Rifai L; Seir RA; Talaat SM; Tunca B; Ziada-Bouchaar H; Velthuizen ME; Sharara AI; Ahadova A; Georgiou D; Vasen HFA;
    Fam Cancer; 2021 Jul; 20(3):215-221. PubMed ID: 33098072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers.
    Hunter JE; Zepp JM; Gilmore MJ; Davis JV; Esterberg EJ; Muessig KR; Peterson SK; Syngal S; Acheson LS; Wiesner GL; Reiss JA; Goddard KA
    Cancer; 2015 Sep; 121(18):3281-9. PubMed ID: 26036338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.
    Stoffel EM; Mangu PB; Gruber SB; Hamilton SR; Kalady MF; Lau MW; Lu KH; Roach N; Limburg PJ; ;
    J Clin Oncol; 2015 Jan; 33(2):209-17. PubMed ID: 25452455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Communication, encouragement, and cancer screening in families with and without mutations for hereditary nonpolyposis colorectal cancer: a pilot study.
    Ersig AL; Williams JK; Hadley DW; Koehly LM
    Genet Med; 2009 Oct; 11(10):728-34. PubMed ID: 19707152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome.
    Stoffel EM; Mercado RC; Kohlmann W; Ford B; Grover S; Conrad P; Blanco A; Shannon KM; Powell M; Chung DC; Terdiman J; Gruber SB; Syngal S
    Am J Gastroenterol; 2010 Aug; 105(8):1851-60. PubMed ID: 20354509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Identification of 2 families with hereditary nonpolyposis colonic cancer (HNPCC) and the Amsterdam criteria. Relevance of the genealogic tree and follow-up].
    Balmaña J; Brunet J; Capellà G; González D; Palicio M; Sancho FJ; Pericay C; López López JJ; Marcuello E
    Med Clin (Barc); 2000 Jan; 114(2):56-9. PubMed ID: 10702951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review.
    Lindor NM; Petersen GM; Hadley DW; Kinney AY; Miesfeldt S; Lu KH; Lynch P; Burke W; Press N
    JAMA; 2006 Sep; 296(12):1507-17. PubMed ID: 17003399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dedicated high-quality service for the management of patients with an inherited risk of colorectal cancer.
    Adams LK; Qiu S; Hunt AK; Monahan KJ
    Colorectal Dis; 2019 Aug; 21(8):879-885. PubMed ID: 30903731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations.
    Halbert CH; Lynch H; Lynch J; Main D; Kucharski S; Rustgi AK; Lerman C
    Arch Intern Med; 2004 Sep; 164(17):1881-7. PubMed ID: 15451763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a population-based approach to familial colorectal cancer.
    Parfrey PS; Dicks E; Parfrey O; McNicholas PJ; Noseworthy H; Woods MO; Negriin C; Green J
    Clin Genet; 2017 May; 91(5):672-682. PubMed ID: 27696385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of predictive genetic testing in management of hereditary non-polyposis colorectal cancer (HNPCC).
    Stanley AJ; Gaff CL; Aittomäki AK; Fabre LC; Macrae FA; St John J
    Med J Aust; 2000 Apr; 172(7):313-6. PubMed ID: 10844916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of familial colorectal cancer and hereditary colorectal cancer syndromes through the Dutch population-screening program: results ofa pilot study.
    van Erp SJ; Leicher LW; Hennink SD; Ghorbanoghli Z; Breg SA; Morreau H; Nielsen M; Hardwick JC; Roukema JA; Langers AM; de Vos Tot Nederveen Cappel WH; Vasen HF
    Scand J Gastroenterol; 2016 Oct; 51(10):1227-32. PubMed ID: 27310819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Missed opportunities: Genetic counseling and testing among an ethnically diverse cohort of women with endometrial cancer.
    Lee J; Gubernick LR; Brodsky AL; Fehniger JE; Levine DA; Gerber D; Asgari SA; Cantor A; Martineau JT; Ginsburg OM; Smith JA; Pothuri B
    Gynecol Oncol; 2018 Oct; 151(1):153-158. PubMed ID: 30077346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of colonoscopic screening in Familial Colorectal Cancer Type X.
    Hatfield E; Green JS; Woods MO; Warden G; Parfrey PS
    Mol Genet Genomic Med; 2018 Nov; 6(6):1021-1030. PubMed ID: 30300963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suboptimal Adherence in Clinical Practice to Guidelines Recommendation to Screen for Lynch Syndrome.
    Jain A; Shafer L; Rothenmund H; Kim CA; Samadder J; Gupta S; Singh H
    Dig Dis Sci; 2019 Dec; 64(12):3489-3501. PubMed ID: 31187321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma.
    Collins V; Meiser B; Gaff C; St John DJ; Halliday J
    Cancer; 2005 Jul; 104(2):273-81. PubMed ID: 15948171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.